Advertisement

The Latest

Biotechnology company RadioMedix has raised $40 million in series A funding; the company plans to use the new funding to advance its flagship radiopharmaceutical, AlphaMedix.

Here are five oncology firsts Becker's has covered since Sept. 12:

Many healthcare systems are using algorithms to identify patients for specialty care, but many underserved groups have incomplete records, resulting in more disparities, according to a study published Oct. 4 in the Journal of the American Medical Association Network Open.

Advertisement